Oncology’s successes must not fail the heart

Anna Wagstaff

Targeted therapies seek to close down signalling pathways that allow tumours to prosper. But these pathways may also be vital to other clinical functions. With rising concern about collateral cardiac damage from cancer treatment comes a call for a new partnership between oncology and cardiology, to avoid problems and to treat them quickly and expertly if they do arise.

Download full article

Be the first to comment

Leave a Reply

Your email address will not be published.


*


UA-77507851-1